National Institute of Allergy and Infectious Diseases; Notice of Meetings, 48433-48434 [2021-18649]

Download as PDF 48433 Federal Register / Vol. 86, No. 165 / Monday, August 30, 2021 / Notices Policy for Extramural Research Administration, 6705 Rockledge Drive, 8th Floor Room 803, Bethesda, Maryland 20892, or call a non-toll-free number 301–435–0941 or Email your request, including your address to ProjectClearanceBranch@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires: Written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information SUPPLEMENTARY INFORMATION: technology to minimize the information collection burden. Title of the Collection: NIH COVID–19 Vaccine Attestation Intake Form. Type of Collection: Emergency. OMB Number: 0925–NEW. Abstract: The U.S. Office of Personnel Management (OPM) approved the U.S. Department of Health and Human Services’ (HHS) request for a variation to a strict application of 5 CFR 339.205 under 5 CFR.1 to promote the efficiency of the Government. Under this variation, HHS may use the authority under 5 CFR 339.205 to mandate COVID–19 vaccinations authorized under Emergency Use Authorizations (EUA) for its patient-facing health care personnel, including its health care applicants and employees, who work in Indian Health Service (IHS) medical facilities, National Institutes of Health (NIH) clinical research facilities, or other HHS facilities that provide direct patient care or clinical research. In addition, the Safer Federal Workforce Task Force created by President Biden’s Executive Order 13991 has instructed Federal Agencies to inquire about the COVID–19 vaccination status of federal employees and on-site contractors. The NIH now has a COVID–19 vaccination requirement for persons working in Building 10 on the Bethesda campus, those with patient contact, or probable patient contact. The proposed information collection will be used to ensure compliance with these requirements, generate the list of persons required to be tested on a routine basis, and will provide important information regarding safety frameworks, guidance, and procedures. The purpose of the information collection is to promote the safety of the federal workplace consistent with the above-referenced authorities, the COVID–19 Workplace Safety: Agency Model Safety Principles established by the Safer Federal Workforce Task Force, and guidance from the Centers for Disease Control and Prevention (CDC) and the Occupational Safety and Health Administration (OSHA). ESTIMATED ANNUALIZED BURDEN TABLE Type of collection Number of respondents Average burden per response (in hours) Total burden hours NIH COVID–19 Vaccine Attestation intake form ............................................. 31,000 1 5/60 2,583 Total .......................................................................................................... ........................ 31,000 ........................ 2,583 Dated: August 24, 2021. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2021–18636 Filed 8–27–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings khammond on DSKJM1Z7X2PROD with NOTICES Number responses per respondent Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council. The meeting will be open to the public. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Individuals who need special assistance, such as sign language interpretation or other reasonable VerDate Sep<11>2014 18:40 Aug 27, 2021 Jkt 253001 accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Allergy and Infectious Diseases Council Date: September 13, 2021 Open: 10:30 a.m. to 11:30 a.m. Agenda: Report of Institute Director Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30 Rockville, MD 20892 (Virtual Meeting). Closed: 11:45 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Health, 5601 Fishers Lane, Room 4G30 Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD, 20892 301–496–7291, fentonm@ niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council Acquired Immune Deficiency Syndrome Subcommittee. Date: September 13, 2021. Open 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30, Rockville, MD 20832 (Virtual Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30, Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD E:\FR\FM\30AUN1.SGM 30AUN1 khammond on DSKJM1Z7X2PROD with NOTICES 48434 Federal Register / Vol. 86, No. 165 / Monday, August 30, 2021 / Notices 20892, 301–496–7291, fentonm@ niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council Microbiology and Infectious Diseases Subcommittee. Date: September 13, 2021. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health 5601 Fishers Lane, Room 4G30, Rockville, MD 20892 (Virtual Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30, Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, fentonm@ niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council Immunology and Transplantation Subcommittee. Date: September 13, 2021. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30Rockville, MD 20892 (Virtual Meeting). Open: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4G30, Rockville, MD 20892 (Virtual Meeting). Contact Person: Matthew J. Fenton, Ph.D., Director, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 4F50, Bethesda, MD 20892, 301–496–7291, fentonm@ niaid.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.niaid.nih.gov/about/advisory-council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) VerDate Sep<11>2014 18:40 Aug 27, 2021 Jkt 253001 Dated: August 25, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HOMELAND SECURITY [FR Doc. 2021–18649 Filed 8–27–21; 8:45 am] [Docket No. USCG–2021–0629; Control Number 1625–0003] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the AIDS Research Advisory Committee, NIAID. The meeting will be open to the public. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov). Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: AIDS Research Advisory Committee, NIAID. Date: September 13, 2021. Time: 1:00 p.m. to 4:00 p.m. Agenda: Report of Division Director and Division Staff. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 8D49, Rockville, MD 20892 (Virtual Meeting). Contact Person: Pamela Gilden, Branch Chief, Science Planning and Operations Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 8D49, Rockville, MD 20852–9831, 301–594–9954, pamela.gilden@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 25, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–18647 Filed 8–27–21; 8:45 am] Frm 00050 Fmt 4703 Sfmt 4703 Coast Guard, DHS. Sixty-day notice requesting comments. ACTION: National Institute of Allergy and Infectious Diseases; Notice of Meeting PO 00000 Information Collection Request to Office of Management and Budget; OMB AGENCY: National Institutes of Health BILLING CODE 4140–01–P Coast Guard In compliance with the Paperwork Reduction Act of 1995, the U.S. Coast Guard intends to submit an Information Collection Request (ICR) to the Office of Management and Budget (OMB), Office of Information and Regulatory Affairs (OIRA), requesting approval of an extension for the following collection of information: 1625–0003, Recreational Boating Accident Report; without change. Our ICR describes the information we seek to collect from the public. Before submitting this ICR to OIRA, the Coast Guard is inviting comments as described below. DATES: Comments must reach the Coast Guard on or before October 29, 2021. ADDRESSES: You may submit comments identified by Coast Guard docket number [USCG–2021–0629] to the Coast Guard using the Federal eRulemaking Portal at https://www.regulations.gov. See the ‘‘Public participation and request for comments’’ portion of the SUPPLEMENTARY INFORMATION section for further instructions on submitting comments. A copy of the ICR is available through the docket on the internet at https:// www.regulations.gov. Additionally, copies are available from: COMMANDANT (CG–6P), ATTN: PAPERWORK REDUCTION ACT MANAGER, U.S. COAST GUARD, 2703 MARTIN LUTHER KING JR. AVE. SE, STOP 7710, WASHINGTON, DC 20593– 7710. FOR FURTHER INFORMATION CONTACT: A.L. Craig, Office of Privacy Management, telephone 202–475–3528, or fax 202– 372–8405, for questions on these documents. SUMMARY: SUPPLEMENTARY INFORMATION: Public Participation and Request for Comments This notice relies on the authority of the Paperwork Reduction Act of 1995; 44 U.S.C. chapter 35, as amended. An ICR is an application to OIRA seeking the approval, extension, or renewal of a Coast Guard collection of information E:\FR\FM\30AUN1.SGM 30AUN1

Agencies

[Federal Register Volume 86, Number 165 (Monday, August 30, 2021)]
[Notices]
[Pages 48433-48434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of meetings of the National Advisory 
Allergy and Infectious Diseases Council.
    The meeting will be open to the public. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (https://videocast.nih.gov). Individuals who need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council
    Date: September 13, 2021
    Open: 10:30 a.m. to 11:30 a.m.
    Agenda: Report of Institute Director
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4G30 
Rockville, MD 20892 (Virtual Meeting).
    Closed: 11:45 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4G30 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD, 20892 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Acquired Immune Deficiency Syndrome Subcommittee.
    Date: September 13, 2021.
    Open 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4G30, 
Rockville, MD 20832 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4G30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD

[[Page 48434]]

20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Microbiology and Infectious Diseases Subcommittee.
    Date: September 13, 2021.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health 5601 Fishers Lane, Room 4G30, 
Rockville, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4G30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Immunology and Transplantation Subcommittee.
    Date: September 13, 2021.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 
4G30Rockville, MD 20892 (Virtual Meeting).
    Open: 1:00 p.m. to 4:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 4G30, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Matthew J. Fenton, Ph.D., Director, Division of 
Extramural Activities, National Institute of Allergy and Infectious 
Diseases, National Institutes of Health, 5601 Fishers Lane, Room 
4F50, Bethesda, MD 20892, 301-496-7291, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.niaid.nih.gov/about/advisory-council, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 25, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18649 Filed 8-27-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.